Answers are grounded in this paper and cite their sources.
At the health systems level, lack of diagnostic ability, inadequate access to trained providers, and limited drug availability provide significant barriers to cancer care delivery. This article outlines an urgent call to action to improve access to precision oncology therapies in lower- and middle-income countries, drawing upon lessons from international efforts in oncology and infectious disease.
No takes yet. Share an insight, caveat, or question.
Bharadwaj et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: